Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: Sulfadimethoxine
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang
Email: enquiry@dycnchem.com

122-11-2

122-11-2 structure

Name: Sulfadimethoxine
Chemical Name: sulfadimethoxine
CAS Number: 122-11-2
Molecular Formula: C₁₂H₁₄N₄O₄S
Molecular Weight: 310.329
Catalog: API Synthetic anti-infective drugs Sulfonamides and synergists
Create Date: 2018-08-31 18:01:28
Modify Date: 2026-07-19 20:27:15
Sulfadimethoxine is a sulfonamide antibiotic.Target: AntibacterialSulfadimethoxine is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies [1].

Name	sulfadimethoxine
Synonyms	sudine 6-Sulfanilamido-2,4-dimethoxy-1,3-diazine n(sup1)-(2,6-dimethoxy-4-pyrimidinyl)-sulfanilamid 4-(p-Aminobenzenesulfonamido)-2,6-dimethoxypyrimidine redifal 2,6-dimethoxy-4-sulfanilamidopyrimidine EINECS 204-523-7 sulphadimethoxine Sulfadimethoxine G0D2490.998mg/mg(ai) neostral 2,4-Dimethoxy-6-sulfanilamido-1,3-pyrimidine aibon -N-((2,6-Dimethoxy-4-pyrimidinyl)sulfanilamide (8CI) radonin Sulfadimethoxine solution,1000ppm omnibon sulfoplan fuxal scandisil bactrovet sulfadimetossina Sulfadimethoxine Solution, 100ppm Sulphanyl acid N-(2,6-dimethoxypyrimidin-4-yl) amide 4-azanyl-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide MFCD00057345 madroxine n(sup1)-(2,6-dimethoxy-4-pyrimidinyl)sulfanilamide albon Sulfadimethoxine for peak identification 4-Amino-N-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide Aibon(TM) madroxin persulfen 2,6-dimethoxy-4-(p-aminobenzenesulfonamido)pyrimidine maxulvet 2,4-dimethoxy-6-sulfanilamido-1,3-diazine T6N CNJ BO1 DO1 FMSWR DZ roscosulf 4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide dimetazina sulfadimetoxin 4-amino-n-(2,6-dimethoxy-4-pyrimidinyl)-benzenesulfonamid diasulfyl dorisul sulfadimethoxydiazine madriqid sulfadimethoxin memcozine madribon madrigid sulfastop Lastin dosul 4-Sulfa-2,6-dimethoxypyrimidine Sulfadimethoxine (base and/or unspecified salts) Dosmin dimethoxysulfadiazine sulxin 4-Amino-N-[2,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide symbio abcid diasulfa metoxidon SULPHADIMETHOXINE BP 88, 25 nosulfan

Description	Sulfadimethoxine is a sulfonamide antibiotic.Target: AntibacterialSulfadimethoxine is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies [1].
Related Catalog	Signaling Pathways >> Anti-infection >> Bacterial Research Areas >> Infection
References	[1]. http://www.drugbank.ca/drugs/DB06150

Density	1.4±0.1 g/cm3
Boiling Point	548.5±60.0 °C at 760 mmHg
Melting Point	200 °C
Molecular Formula	C₁₂H₁₄N₄O₄S
Molecular Weight	310.329
Flash Point	285.5±32.9 °C
Exact Mass	310.073578
PSA	124.81000
LogP	1.48
Vapour Pressure	0.0±1.5 mmHg at 25°C
Index of Refraction	1.623
Storage condition	2-8°C
Water Solubility	NH4OH 1 M: 50 mg/mL, clear, faintly yellow

CHEMICAL IDENTIFICATION

RTECS NUMBER :: WO9030000

CHEMICAL NAME :: Sulfanilamide, N(sup 1)-(2,6-dimethoxy-4-pyrimidinyl)-

CAS REGISTRY NUMBER :: 122-11-2

BEILSTEIN REFERENCE NO. :: 0306856

LAST UPDATED :: 199706

DATA ITEMS CITED :: 20

MOLECULAR FORMULA :: C12-H14-N4-O4-S

MOLECULAR WEIGHT :: 310.36

WISWESSER LINE NOTATION :: T6N CNJ BO1 DO1 FMSWR DZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 40(9),115,1975

TYPE OF TEST :: LD - Lethal dose

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 58(12),9,1993

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 40(9),115,1975

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 866 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,386,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 791 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,386,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 844 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,386,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: >3200 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,386,1982

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 140 mg/kg

TOXIC EFFECTS :: Vascular - BP lowering not characterized in autonomic section

REFERENCE :: CHTHBK Chemotherapy (Basel). (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.13- 1968- Volume(issue)/page/year: 14,37,1969

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: >1 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,386,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 1 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,386,1982 ** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 9100 mg/kg/13W-I

TOXIC EFFECTS :: Endocrine - thyroid weight (goiter) Nutritional and Gross Metabolic - weight loss or decreased weight gain

REFERENCE :: TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 1,28,1959

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 24 gm/kg/24D-I

TOXIC EFFECTS :: Behavioral - alteration of operant conditioning Liver - other changes Kidney, Ureter, Bladder - other changes

REFERENCE :: GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 40(9),115,1975

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 60 gm/kg/30D-I

TOXIC EFFECTS :: Endocrine - toxic goiter-hypofunction Endocrine - changes in thyroid weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)

REFERENCE :: JTSCDR Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor, Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976- Volume(issue)/page/year: 8,47,1983 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 3 gm/kg

SEX/DURATION :: female 9-14 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system

REFERENCE :: SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. Volume(issue)/page/year: 13,17,1973

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 11970 mg/kg

SEX/DURATION :: male 6 week(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)

REFERENCE :: JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- Volume(issue)/page/year: 81,259,1987

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 12 gm/kg

SEX/DURATION :: female 7-12 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - eye/ear

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,1005,1973

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 6 gm/kg

SEX/DURATION :: female 7-12 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,1005,1973

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 3 gm/kg

SEX/DURATION :: female 7-12 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - musculoskeletal system

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 7,1005,1973

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 2 gm/kg

SEX/DURATION :: female 10 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)

REFERENCE :: SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. Volume(issue)/page/year: 13,85,1973 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X2763 No. of Facilities: 403 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 4029 (estimated) No. of Female Employees: 2015 (estimated)

Symbol	GHS07
Signal Word	Warning
Hazard Statements	H315-H317-H319-H335
Precautionary Statements	P280-P305 + P351 + P338
Personal Protective Equipment	dust mask type N95 (US);Eyeshields;Faceshields;Gloves
Hazard Codes	Xi: Irritant;
Risk Phrases	R36/37/38
Safety Phrases	S26-S36/37-S24/25-S23
RIDADR	3249
WGK Germany	3
RTECS	WO9030000
Packaging Group	III
Hazard Class	6.1(b)
HS Code	2935009090

37063-70-0

~79%

122-11-2

Literature: Luk'yanov, A. V.; Onoprienko, V. S.; Borodina, K. S.; Zasosov, V. A.; Van'kovich, E. V.; et al. Pharmaceutical Chemistry Journal, 1980 , vol. 14, # 9 p. 640 - 644 Khimiko-Farmatsevticheskii Zhurnal, 1980 , vol. 14, # 9 p. 87 - 91

100-05-0

122-11-2

Literature: Pharmaceutical Chemistry Journal, , vol. 14, # 9 p. 640 - 644 Khimiko-Farmatsevticheskii Zhurnal, , vol. 14, # 9 p. 87 - 91

98-74-8

122-11-2

Literature: Pharmaceutical Chemistry Journal, , vol. 14, # 9 p. 640 - 644 Khimiko-Farmatsevticheskii Zhurnal, , vol. 14, # 9 p. 87 - 91

555-25-9

122-11-2

Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142

77767-96-5

122-11-2

Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142

3289-50-7

122-11-2

Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142

121-60-8

122-11-2

Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142

Precursor 7
37063-70-0 100-05-0 98-74-8 555-25-9
77767-96-5 3289-50-7 121-60-8
DownStream 0

HS Code	2935009090
Summary	2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2732746-81-3	2414476-23-4
2254670-10-3	2241742-07-2
1269825-20-8	2385440-36-6
2139677-45-3	1335053-18-3
2733903-38-1	2733527-68-7